Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial

Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial

Abstract Objectives To assess the hypothesis that an adjunctive therapy with methylprednisolone and unfractionated heparin (UFH) or with methylprednisolone and low molecular weight heparin (LMWH) are more effective in reducing any-cause mortality in critically-ill ventilated patients with pneumonia...

Full description

Bibliographic Details
Main Authors: Stefano Busani, Martina Tosi, Pasquale Mighali, Paola Vandelli, Roberto D’Amico, Marco Marietta, Francesco Forfori, Abele Donati, Gilda Cinnella, Amato De Monte, Daniela Pasero, Giacomo Bellani, Carlo Tascini, Giuseppe Foti, Marco Ranieri, Massimo Girardis
Format: Article
Language:English
Published: BMC 2020-08-01
Series:Trials
Subjects:
COVID-19
Randomized controlled trial
Protocol
Low-molecular weight heparin
Unfractionated heparin
Methylprednisolone
Online Access:http://link.springer.com/article/10.1186/s13063-020-04645-z

Internet

http://link.springer.com/article/10.1186/s13063-020-04645-z

Similar Items